 |
0 Diseases |  |
0 Trials |
|
0 Trials |  |
11 News |  |
- ||| VBI-1501A / VBI Vaccines
Trial completion, Trial primary completion date: Study to Evaluate Safety, Tolerability, and Immunogenicity of Candidate Human Cytomegalovirus Vaccine in Healthy Adults (clinicaltrials.gov) - Dec 14, 2017
P1, N=128, Completed, Sponsor: VBI Vaccines Inc.
Recruiting --> Completed | Trial primary completion date: Aug 2017 --> Sep 2016
- VBI-1501A / VBI Vaccines
New P1 trial: Study to Evaluate Safety, Tolerability, and Immunogenicity of Candidate Human Cytomegalovirus Vaccine in Healthy Adults (clinicaltrials.gov) - Jul 11, 2016
P1, N=125, Recruiting, Sponsor: VBI Vaccines Inc.